USP's Therapeutic Peptides Expert Panel discusses manufacturing processes and impurity control for synthetic peptide APIs.
Harold Rode
Advertisement
Harold Rode is a consultant at Rode Biologics Consulting.
Articles by Harold Rode
USP evaluates raw materials used in the chemical synthesis of peptides.
USP evaluates quality attributes for synthetic peptides.
Advertisement
Latest Updated Articles
Control Strategies for Synthetic Therapeutic Peptide APIs Part II: Raw Material ConsiderationsPublished: April 2nd 2014 | Updated:
Control Strategies for Synthetic Therapeutic Peptide APIs—Part I: Analytical ConsiderationPublished: March 2nd 2014 | Updated:
Control Strategies for Synthetic Therapeutic Peptide APIs Part III: Manufacturing Process ConsiderationsPublished: May 2nd 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
2
Everything to Know About Pharmaceutical Tariffs in 2025
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
